| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | $6.6B | $6.6B | $7.0B | $7.1B | $5.6B | $4.5B | $5.0B | $4.0B |
| Gross Profit | — | — | — | — | — | $0.3B | $0.3B | $0.2B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.7B | $0.7B | $0.6B | $0.5B | $0.5B | $0.5B | $0.5B | $0.4B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.5B | $0.9B | $1.2B | $0.4B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $0.75 | $4.19 | $7.34 | $10.09 | $3.43 | $0.57 | $0.73 | $0.00 |
| EPS (Diluted) | $0.74 | $4.14 | $7.25 | $9.95 | $3.38 | $0.56 | $0.72 | $0.44 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.2B | $6.8B | $6.6B | $6.2B | $4.6B | $4.1B | $3.8B | $3.3B |
| Current Assets | $3.5B | $3.3B | $3.1B | $3.4B | $2.7B | $2.2B | $2.1B | $2.1B |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $3.0B | $2.5B | $2.5B | $3.0B | $2.3B | $2.2B | $2.1B | $1.8B |
| Current Liabilities | $1.3B | $0.8B | $0.8B | $1.4B | $1.0B | $0.7B | $0.7B | $0.5B |
| Stockholders' Equity | $4.2B | $4.3B | $4.1B | $3.3B | $2.3B | $1.9B | $1.6B | $1.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.7B | $0.9B | $1.3B | $0.7B | $0.2B | $0.8B | $0.0B | $0.2B |
| Investing Cash Flow | $-0.3B | $-0.3B | $-0.8B | $-0.7B | $-0.2B | $-0.2B | $-0.5B | $-0.1B |
| Capital Expenditures | $0.4B | $0.3B | $0.6B | $0.4B | $0.2B | $0.2B | $0.1B | $0.2B |
| Financing Cash Flow | $-0.2B | $-0.3B | $-0.6B | $0.2B | $-0.1B | $-0.2B | $-0.0B | $0.3B |